Archive: 29/01/2017
Delays in access to cancer medicines and unjustifiable price rises disadvantage patients
Amsterdam, The Netherlands: Cancer patients are living longer and in many cases the disease is becoming chronic rather than acute. Access to drugs that help extend life and improve quality of life, and fair prices for those ...
Jan 29, 2017
Experts predict melanoma death rates will fall by 2050
By 2050 the death rates from malignant melanoma will have decreased from their current levels but the numbers of people dying from the disease will have increased due to the aging of populations.
Jan 29, 2017
The immunotherapy, pembrolizumab, is active against mucosal melanoma tumors
Clinical trials of a new immunotherapy, pembrolizumab, have shown that it prolongs life significantly for patients with bladder cancer and is active against a rare sub-type of melanoma, called mucosal melanoma. The findings ...
Jan 29, 2017